These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34964090)

  • 41. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder.
    Noblett K; Siegel S; Mangel J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Bennett J; Zylstra S; Kan F; Berg KC
    Neurourol Urodyn; 2016 Feb; 35(2):246-51. PubMed ID: 25546568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
    Hoda MR; Fornara P
    Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An overview of sacral neuromodulation: a treatment for patients with symptoms of lower urinary tract dysfunction.
    Fletcher N
    Br J Nurs; 2020 Aug; 29(15):848-856. PubMed ID: 32790556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of sacral neuromodulation on pudendal nerve function and female sexual function.
    Parnell BA; Howard JF; Geller EJ
    Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. To stage or not to stage?-A cost minimization analysis of sacral neuromodulation placement strategies.
    Sun AJ; Harris CR; Comiter CV; Elliott CS
    Neurourol Urodyn; 2019 Aug; 38(6):1783-1791. PubMed ID: 31215706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-Effectiveness Analysis Between Sacral Neuromodulation and OnabotulinumtoxinA for the Treatment of Refractory Overactive Bladder in Women: A Systematic Review.
    Gerjevic KA; Ahmad S; Strohbehn K; Riblet N
    Female Pelvic Med Reconstr Surg; 2021 Aug; 27(8):481-487. PubMed ID: 34074937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Affective symptoms and quality of life in patients with voiding or storage dysfunction: Results before and after sacral neuromodulation: A prospective follow-up study.
    Jairam R; Drossaerts J; Vrijens D; Leue C; van Kerrebroeck P; van Koeveringe G
    Neurourol Urodyn; 2018 Jun; 37(5):1801-1808. PubMed ID: 29504634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patients.
    Reekmans M; Janssen JMW; Vrijens DMJ; Smits MAC; van Koeveringe GA; Van Kerrebroeck PEVA
    Neurourol Urodyn; 2021 Jun; 40(5):1120-1125. PubMed ID: 33829519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sacral Neuromodulation Using a Novel Device with a Six-contact-point Electrode for the Treatment of Patients with Refractory Overactive Bladder: A Multicenter, Randomized, Single-blind, Parallel-control Clinical Trial.
    Liao L; Zhou Z; Chen G; Xu Z; Huang B; Chong T; Chen Q; Wei Z; Shen B; Chen Z; Ling Q; Weng Z; Jiang H; Shi B; Li Y; Wang Y
    Eur Urol Focus; 2022 Nov; 8(6):1823-1830. PubMed ID: 35525837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-Term Functional Outcomes of S3 Sacral Neuromodulation for the Treatment of Idiopathic Overactive Bladder.
    Ismail S; Chartier-Kastler E; Perrouin-Verbe MA; Rose-Dite-Modestine J; Denys P; Phé V
    Neuromodulation; 2017 Dec; 20(8):825-829. PubMed ID: 28967986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation.
    Siegel S; Noblett K; Mangel J; Bennett J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Zylstra S; Kan F; Berg KC
    J Urol; 2018 Jan; 199(1):229-236. PubMed ID: 28709886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Do patients experience decisional regret after sacral neuromodulation for refractory overactive bladder?
    Kessler L; Illinsky D; Laudano M; Abraham NE
    Neurourol Urodyn; 2024 Jan; 43(1):22-30. PubMed ID: 37830272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuromodulation for intractable OAB.
    Apostolidis A
    Neurourol Urodyn; 2011 Jun; 30(5):766-70. PubMed ID: 21661027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Results of sacral nerve modulation for treatment of overactive bladder].
    Braun PM; Böhler G
    Urologe A; 2006 Jul; 45(7):835-40. PubMed ID: 16773383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is a 50% improvement threshold adequate to justify progression from sacral neuromodulation testing to implant?
    Charles DK; Everett RG; Prebay ZJ; Landowski TP; O'Connor RC; Guralnick ML
    Neurourol Urodyn; 2021 Aug; 40(6):1524-1531. PubMed ID: 34005836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique.
    Adelstein SA; Lee W; Gioia K; Moskowitz D; Stamnes K; Lucioni A; Kobashi KC; Lee UJ
    Neurourol Urodyn; 2019 Aug; 38(6):1595-1601. PubMed ID: 31044466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
    Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
    Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current information on sacral neuromodulation and botulinum toxin treatment for refractory idiopathic overactive bladder syndrome: a review.
    Leong RK; De Wachter SG; van Kerrebroeck PE
    Urol Int; 2010; 84(3):245-53. PubMed ID: 20389150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism and Priority of Botulinum Neurotoxin A versus Sacral Neuromodulation for Refractory Overactive Bladder: A Review.
    Zhang Y; Ji F; Liu E; Wen JG
    Urol Int; 2021; 105(11-12):929-934. PubMed ID: 34130295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urologists' referral attitude for sacral neuromodulation for treating refractory idiopathic overactive bladder syndrome: discrete choice experiment.
    Kessler TM; Maric A; Mordasini L; Wöllner J; Pannek J; Mehnert U; van Kerrebroeck PE; Bachmann LM
    Neurourol Urodyn; 2014 Nov; 33(8):1240-6. PubMed ID: 24127359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.